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Background/aim: We aimed to show the role of determination of optic nerve sheath diameter (ONSD) by bedside ultrasonography in
an emergency department in the diagnosis of cerebrovascular disorders and its correlation with the clinical picture.
Materials and methods: This prospective cross-sectional study included 55 patients with cerebrovascular disorders and 53 controls.
Age, sex, ONSD, comorbid disease status, and multidetector computed tomography results of all subjects and application periods and
National Institutes of Health Stroke Scale (NIHSS) scores of the patient group were evaluated.
Results: The ONSD of the patient and control groups was determined as a median of 5.7 mm and 3.6 mm, respectively. The ONSD
of the patient group was determined to be significantly higher than that of the control group (P < 0.05). A positive relationship was
determined between NIHSS scores and ONSD values (P < 0.05). The specificity and sensitivity values were determined as 98.1% and
81.8%, respectively, for a cutoff value of 5 mm and as 100% and 72.7%, respectively, for a cutoff value of 6 mm.
Conclusion: This study showed that bedside measurement of ONSD is an easy, cheap, and noninvasive method that can be used to
support the diagnosis and evaluation of patients with acute stroke.
Key words: Optic nerve, cerebrovascular disorders, ultrasonography

1. Introduction
Cerebrovascular disorders (CVDs) are pathologies with
higher mortality in the short term and higher morbidity
rates in the long term. These are important pathologies in
emergency departments (EDs) due to the higher possibility
of reperfusion and the need to be able to decrease the
incidences of mortality and morbidity. Timely treatment
and supportive care of stroke patients in the ED is crucial
for patient outcomes (1). The annual prevalence of stroke
has been reported to be 0.15% in developed countries
and this rate is gradually increasing. It is the second most
frequent cause of death in the European Union and is
ranked third globally (2).
CVD results in edema depending on the deterioration
of the autoregulation of the brain. Cerebral edema must
be diagnosed and treated as it causes an increase in
intracranial pressure (ICP) and damages the patient’s
* Correspondence: dryuzbasioglu@hotmail.com

health (3). There are invasive and noninvasive methods
that can be used to determine the increase of ICP (4–6).
The gold standard for diagnosing increased ICP is the use
of intracranial devices. However, this requires an invasive
method that has multiple disadvantages, namely severe
complications (infection, hemorrhage, malfunction)
and nonfeasibility due to lack of neurosurgical expertise
or contraindications (coagulopathy, thrombocythemia)
(7). There have been contradictory results in the use of
noninvasive methods (6,8,9). Recent studies have shown
a correlation between optic nerve sheath (ONS) thickness
and ICP (10–13).
Ultrasonography (US) of the intraconal segment of
the optic nerve (ON) and its sheath is an easy, cheap,
noninvasive method and provides a very promising
bedside tool for the detection of increased ICP. The ON
and its sheath are tubular structures of about 5 cm in
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length in which the intraconal segment is easily evaluable
by US. Histologically, the ONS is surrounded by the same
meningeal layers as the brain (14,15). The ON appears
as a linear structure located inside the ONS. The ON is
surrounded by hypoechoic cerebrospinal fluid in US
images. Some US studies have reported that enlargement
of ONS diameter (ONSD) is an early sign of increased ICP
(13,16–20).
In this study, it was aimed to show the role of determination
of the ONSD in the diagnosis of CVDs and its correlation
with the clinical picture.
2. Materials and methods
This prospective, cross-sectional study included 55
patients meeting the criteria with CVDs and 53 controls
at a referral emergency center of Atatürk Training and
Research Hospital, located in Ankara, Turkey. Approval
for the study was granted by the ethics committee of this
hospital (23 July 2012, no: 45) and informed consent was
obtained from all the study participants.
2.1. Patient and control groups
After a complete medical history and family history were
obtained, all patients and control subjects underwent
a detailed neuroophthalmological examination. The
diagnosis of CVD was made according to Emergency
Medicine Stroke Guidelines (1,3). After general physical
and neuroophthalmological examination, multidetector
computed tomography (MDCT) acquisitions were
obtained from all subjects. If needed, diffusion-weighted
MRI was obtained.
Evaluation was made of the age, sex, presentation time
to the ED, ONSD, arterial pressure, pulse rate, comorbid
disease frequency, drug use, computed tomography results,
and National Institutes of Health Stroke Scale (NIHSS)
scores of the 55 patients who presented with CVD to our
ED. To minimize the effects of age, sex, and comorbid
diseases, the control group was composed of 53 people
with similar age and sex characteristics. Comparisons were
made for age, sex, and ONSD of the patients and controls.
The NIHSS score was compared with the ONSD. Cutoff
value and specificity and sensitivity levels were determined
for ONSD based on clinical and MDCT findings as a gold
standard reference together.
Individuals under the age of 18 years were excluded.
Vascular dementia, hypertensive encephalopathy,
transient ischemic attack, liver failure, chronic kidney
failure, trauma, optic neuritis, cystic lesion around the
optic nerves, optic nerve trauma, orbital/cavernous sinus
mass, pregnancy, neurofibromatosis, and breast-feeding
were also exclusion criteria for the study.
2.2. ONS diameter measurements
ONSD was determined with a 7.5-MHz linear probe and US
device (Mindray Biomedical Co., Shenzhen, China). Eye
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US exams for measurements of ONSD were implemented
with the closed-eye method. The linear probe with gel
was applied either within the protective cover or directly
onto the closed eye. The eyeball was viewed in the sagittal
and axial planes. Following the determination of the ONS
through US imaging, the ONSD measurements were taken
0.3 cm posterior from the globe. It takes 2 min to apply US
to both eyes. Each optic nerve was measured three times
and the mean number was recorded. The arithmetic mean
values of right and left ONSDs were entered in the analysis.
2.3. Statistical analyses
Analysis of data was performed using SPSS for Windows
15. The conformity of the continuous and discrete
numerical variables to normal distribution was analyzed
with the Kolmogorov–Smirnov test. Descriptive statistics
were shown as mean ± standard deviation or median and
interquartile range (IQR) for the continuous and discrete
numerical variables, and categorical variables were shown
as number of cases (n) and percentages (%). Categorical
variables were evaluated with the chi-square test and
parametric and nonparametric data were analyzed with
the Student t and Mann–Whitney U tests, respectively.
The cutoff value and specificity and sensitivity levels were
determined through ROC analysis. Unless indicated
otherwise, P < 0.05 was accepted as statistically significant.
3. Results
The median ages of the patients and control groups in the
study were determined as 74 years (IQR: 18) and 72 years
(IQR: 13.5), respectively. The rate of males in the patients
group was 56.4%, while this rate was 67.9% for the control
group. No significant difference was determined between
the groups in terms of age or sex (P > 0.05). The ONSD of
the patient and control group was determined as a median
of 5.7 mm (IQR: 0.85) and 3.6 mm (IQR: 0.59), respectively.
The ONSD of the patient group was determined to be
significantly higher than that of the control group (P <
0.05) (Table 1; Figure 1).
While systolic blood pressure and diastolic blood pressure
were significantly higher in the patient group (P < 0.05),
pulse rates were similar to the control group (P > 0.05).
While comorbid disease frequency (hypertension, diabetes
mellitus, presence of atrial fibrillation, and drug use
frequency) was significantly higher in the patient group
(P < 0.05), former stroke history and chronic obstructive
pulmonary disease frequencies were similar.
The mean NIHSS score of the patients was 18.1 ± 6.4 and
the median value of the presentation time at the ED was 4 h
(IQR: 4.7). Patients showed 7.2% hemorrhagic infarct and
54.5% ischemic infarct on cranial tomography (CT), while
38.3% of the patients had no findings on CT (Table 1).
When the ONSDs of the patients were evaluated according
to the presence or absence of CT findings, the ONSD of
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Table 1. Characteristics of the groups.
Parameters

Discrimination

Patients (n: 55)

Controls (n: 53)

P-value

Age

Median (IQR)

74 (18)

72 (13.5)

0.601*

Male: n (%)

31 (56.4)

36 (67.9)

Female: n (%)

24 (43.6)

17 (32.1)

Median (IQR)

5.7 (0.85)

3.6 (0.59)

<0.001*

SBP

Mean ± SD

161.1 ± 20.3

135.1 ± 22.7

<0.001**

DBP

Mean ± SD

91.1 ± 13.6

75.4 ± 14.9

<0.001**

Pulse

Mean ± SD

84.8 ± 24.6

82.6 ± 22.6

0.595**

Comorbid disease

n (%)

50 (90.9)

28 (52.8)

<0.001**

Hypertension

n (%)

37 (67.3)

13 (24.5)

<0.001**

Diabetes mellitus

n (%)

31 (56.4)

11 (20.8)

<0.001**

Atrial fibrillation

n (%)

25 (45.5)

5 (9.4)

<0.001**

Stroke history

n (%)

7 (12.7)

8 (15.1)

0.722**

COPD

n (%)

7 (12.7)

2 (3.8)

0.092**

Drug use

n (%)

48 (87.3)

21 (39.6)

<0.001**

NIHSS

Mean ± SD

18.1 ± 6.4

-

-

Presentation time

Median (IQR)

4 (14.7)

-

-

Hemorrhage on CT

n (%)

4 (7.2)

-

-

Ischemia on CT

n (%)

30 (54.5)

-

-

Normal CT findings

n (%)

21 (38.3)

-

-

Sex
ONSD

0.216**

*: Mann–Whitney U test, **: chi-Square, ***: Student t-test, ONSD: optic nerve sheath diameter, SBP: systolic blood
pressure, DBP: diastolic blood pressure, NIHSS: National Institute of Health Stroke Scale, COPD: chronic obstructive
pulmonary disease, CT: cranial tomography, SD: standard deviation, IQR: interquartile range.

Figure 1. Graphical display of the ONSD of the groups.
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the patients with CT findings was 5.24 ± 0.81 and the
ONSD diameter of the patients without CT findings was
4.41 ± 1.21 mm. This difference was statistically significant
(P < 0.05). There was a weak positive correlation between
the NIHSS score of the patients and the ONSD (P < 0.05,
r: 0.363). There was no relationship between the ONSD
values of the patients and their age and time of presentation
(P > 0.05) (Table 2).
The specificity and sensitivity values were determined as
98.1% and 81.8%, respectively, for a cutoff value of 5 mm
and as 100% and 72.7%, respectively, for a cutoff value of
6 mm. The area under the curve was determined as 0.99
(95% confidence interval: 0.978–1.0) (Figure 2).

4. Discussion
In this study, we showed that the ONSD measured
by bedside US was increased in patients with stroke.
However, we found a weak positive correlation between
ONSD enlargement and stroke severity, although it was
statistically significant.
The World Health Organization has described CVD as a
clinical condition that develops suddenly due to vascular
reasons, continues for more than 24 h, and results in focal
or global cerebral dysfunction (21).
Brain tissue uses 20% of the entire cardiac output and
25% of all oxygen flow. Cerebral blood flow is the most
important factor that affects brain function. Ischemia

Table 2. Relationships between ONSD and NIHSS, presentation time, and age.
Correlation coefficient

P-value

Number of patients (n)

NIHSS

0.363

0.006

55

Age

0.010

0.919

108*

Presentation time

0.005

0.969

55

*: Pearson correlation, ONSD: optic nerve sheath diameter, NIHSS: National Institute of Health Stroke Scale.

Figure 2. ROC curve for ONSD in CVD cases.
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develops at the tissue level as a result of a thromboembolic
event or hemorrhage in the clinical picture of CVD (22).
As sufficient energy will not be able to be provided for
the Na,K-ATPase pump as a result of this ischemia,
there will be Na and accompanying water input into the
cells. Consequently, cytotoxic edema and, in subsequent
periods, cell necrosis develop. Enzymes and free radicals in
the cells fragmented as a result of necrosis are released and
enter a vicious cycle that causes more neuron destruction.
Changes in the cerebral blood flow developing as a result
of CVD, the breakdown of cerebral perfusion pressure due
to edema that develops at the tissue level, and ineffective
CSF circulation cause an increase in ICP (17,22,23).
The ON is unique because it represents an extension of the
central nervous system and has a cover (dura, arachnoid,
and pia) (24). The positive relationships between raised
ICP and the dilatation of the ONS and papillae edema have
been known for several years (25–27).
Watanabe et al. (28) and Moretti et al. (29) stated that
the ONSD decreased with CSF drainage in patients with
intracerebral hemorrhage. In the current study, ONSD was
seen to increase significantly as the clinical condition of
the patient worsened. The main reason for this may be the
development of altered ONSD caused by the increasing
ICP in stroke patients creating a rising pressure on the
optic nerve and perineuronal CSF circulation. Another
mechanism that may cause an increase in the ONSD could
be that the ON, which is accepted as an extension of the
brain, affects the ONSD with the effect of raised cranial
perfusion pressure. In addition, it must be remembered
that papillary edema, which is caused by ICP, may lead to
increased ONSD (26,27).
In some studies, ONSD has been reported as 4.9–5.9
mm in cases of ICP (17,20,30,31). Soldatos et al. (17)
determined ONSD as 6.1 mm in patients with severe brain
injuries, 4.2 mm in moderate-severe injuries, and 3.6 mm
in the control group. Kimberly et al. (13) reported that the
mean ONSD in patients with ICP of <20 cmH2O was 4.4
mm, and it was 5.4 mm in patients with ICP >20 cmH2O.
Skoloudík et al. (32) emphasized that ONSD enlargement
was not detected in any acute ischemic stroke patients or
healthy volunteers, but it was detected in 86% of patients
with acute intracerebral hemorrhage.
In the current study, ONSD was determined as 5.7 mm
in the patient group. These data are consistent with
the literature. In this study, it was thought that ICP had

increased as a result of the mass effect of the cerebral
edema. In these patients, hemorrhagic infarcts develop,
and consequently an increase occurs in the ONSD. It can
be considered that the ONSD varied with the ICP changes
in such patients and therefore the values determined were
significant.
NIHSS scores have been reported to be effective in showing
the general status of patients and mortality rates (33,34). In
one study, however (34), no relationship was determined
between NIHSS score and ONSD. In the current study, a
significant relationship was found between NIHSS score
and ONSD. It can be considered that the magnitude of
the involvement area in ischemic infarcts and the status
of hematoma (magnitude, extension to ventricle or
peripheral tissues) in hemorrhagic infarcts are changing
the clinical picture and ICP of the patients.
Sahoo et al. (18) stated that the sensitivity and specificity
values were 100% and 91%, respectively, for a cutoff value
of 5 mm and 100% and 73.6%, respectively, for a cutoff
value of 6 mm for severe traumatic brain injury patients.
Amini et al. (20) reported that ONSD of greater than
5.5 mm predicted an ICP of ≥20 cmH2O with sensitivity
and specificity of 100%. Soldatos et al. (17) reported
the sensitivity and specificity values as 71% and 100%,
respectively, when the cutoff value was 5.7 mm for adult
brain injury patients. In the current study, the specificity
and sensitivity values were determined as 98% and 82%,
respectively, for a cutoff value of 5 mm and as 100% and
72.7%, respectively, for a cutoff value of 6 mm for patients
with cerebrovascular disorders. These results show
similarity with other studies in literature.
There are some limitations of our study. First, the ONSD
measurements were not taken by a single expert. Second,
ICP measurements were not made for the study patients
because appropriate recording is not possible for stroke
patients. The US application time could not be standardized
due to the differences in the application period of the
patients included in the study. Differences between groups
in terms of comorbid diseases is another limitation. In the
future, larger, randomized, controlled multicenter trials
are needed to support our findings.
In conclusion, the bedside measurement of ONSD is a
quick, easy, cheap, and noninvasive method that can be
a useful tool in evaluation of patients with acute stroke.
It can be used to support the diagnosis and for quick
evaluation for treatment.
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